Charles River Laboratories

Healthcare · Diagnostics & Research

278.10$ -1.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Charles River Laboratories (CRL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 4,015 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CRL
Line item	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	193	219	307	466	555	614	767	1,122	1,058	1,231	1,343	1,203	1,133	1,143	1,130	1,166	1,298	1,363	1,681	1,858	2,266	2,621	2,924	3,540	3,976	4,129	4,050	4,015
Cost of Revenue	123	147	187	298	346	380	435	604	652	752	833	749	749	740	737	771	825	832	1,037	1,157	1,426	1,663	1,850	2,206	2,513	2,627	2,718	2,790
Gross Profit	71	85	120	167	209	234	289	390	407	478	511	423	385	402	392	395	473	531	644	701	840	958	1,074	1,335	1,463	1,503	1,332	1,226
Research & Development	–	–	–	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–
Selling, General & Administrative	34	40	51	68	82	90	121	190	181	218	230	234	227	199	207	224	264	283	368	365	420	486	529	620	665	750	751	723
Total Operating Expenses	35	42	55	77	87	95	131	205	218	251	960	253	683	228	226	244	295	325	406	413	509	607	641	745	812	885	1,104	718
Operating Income	35	43	65	90	122	139	158	185	188	227	-450	170	-299	174	166	151	178	206	238	288	331	351	433	590	651	617	227	508
Interest Expense	2.1	8.3	67	27	27	6.6	8.7	23	193	15	14	22	34	41	33	21	12	15	28	30	64	61	86	74	59	137	126	107
Pre-Tax Income	36	33	26	69	114	133	153	160	177	217	-461	149	-334	133	130	138	178	195	223	297	282	304	447	481	623	581	93	-100
Income Tax Expense	14	16	7.8	27	44	51	61	17	50	59	62	40	0.0	17	28	33	48	43	67	171	54	50	82	82	130	101	68	43
Net Income	23	17	-11	35	50	80	90	142	-56	154	-522	114	-337	110	97	103	127	149	155	123	226	252	364	391	486	475	10	-144
EBITDA	46	59	84	119	148	170	202	275	273	322	-356	263	-205	260	244	256	286	305	377	458	507	563	768	820	986	1,032	581	411

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings